Description：

ACY-738 demonstrates inhibitory activity against recombinant HDAC6 with IC50 values of 1.7 nM, with respective average selectivity over class I HDACs being 100-fold. IC50 value: 1.7 nM Target: HDAC6 in vitro: ACY-738 significantly reduces the number of marbles buried, to a similar degree as a non-sedating (10 mg/kg) dose of the common anxiolytic CDP. in vivo: ACY-738 induces dramatic increases in α-tubulin acetylation in brain and stimulate mouse exploratory behaviors in novel, but not familiar environments. In addition, ACY-738 given acutely at a dose of 50 mg/kg significantly decreased latency to eat in the NIH test, although this effect was not as potent as that of CDP. In the EPM, a test sensitive to anxiolytics but not antidepressants, neither ACY-738 produces behavioral changes, whereas CDP markedly increased the time in the open arms of the maze.

Chemical Information：

Molecular Weight (MW)		270.29
Formula		C14H14N4O2
CAS No.		1375465-91-0
Solubility (25°C) *	DMSO	≥ 32 mg/mL
	Water
	Alcohol

Bought notes(bought amounts latest0)

No one bought this product

Total 0 records, divided into1 pages. First Prev Next Last